Autism Spectrum Disorder Trial, Recruiting (NCT04727489)

Autism Spectrum Disorder Trial, Recruiting NCT04727489 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT04727489 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have Autism Spectrum Disorder (ASD):

You have been formally diagnosed with ASD using recognised diagnostic tools and expert assessment
You are at least 24 months (2 years) old (there is no upper age limit)
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance (such as national health or social security coverage)
You (or your parent/legal guardian if you are a minor or under guardianship) have agreed to take part by signing a consent form

If you do not have ASD (acting as a comparison participant):

You are at least 24 months (2 years) old
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance
You (or your parent/legal guardian) have agreed to take part by signing a consent form

If you are a family member of someone with ASD or of a comparison participant:

You are at least 24 months (2 years) old
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance
You (or your parent/legal guardian) have agreed to take part by signing a consent form

Who may not be able to join:

If you have ASD:

You have a severe intellectual disability (an IQ below 35, or a developmental age under 18 months)
You have a personal history of certain mental health conditions, such as schizophrenia, bipolar disorder, substance use disorder (not including tobacco), recurring severe depression, or a severe and unstable anxiety disorder
You have a personal history of certain neurological conditions, such as epilepsy or another serious neurological disease

If you are a comparison participant or a family member of anyone in the trial:

You have a medical, psychiatric, or physical health condition that would make participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard Delorme, M.D, Ph.D, Institut National de la Santé Et de la Recherche Médicale, France

Phone: +33662725334

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04727489

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +33662725334

More information: https://clinicaltrials.gov/study/NCT04727489

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

If you have Autism Spectrum Disorder (ASD):

You have been formally diagnosed with ASD using recognised diagnostic tools and expert assessment
You are at least 24 months (2 years) old (there is no upper age limit)
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance (such as national health or social security coverage)
You (or your parent/legal guardian if you are a minor or under guardianship) have agreed to take part by signing a consent form

If you do not have ASD (acting as a comparison participant):

You are at least 24 months (2 years) old
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance
You (or your parent/legal guardian) have agreed to take part by signing a consent form

If you are a family member of someone with ASD or of a comparison participant:

You are at least 24 months (2 years) old
Your general physical and mental health allows you to have a blood test taken safely
You are covered by social insurance
You (or your parent/legal guardian) have agreed to take part by signing a consent form

Who may not be able to join:

If you have ASD:

You have a severe intellectual disability (an IQ below 35, or a developmental age under 18 months)
You have a personal history of certain mental health conditions, such as schizophrenia, bipolar disorder, substance use disorder (not including tobacco), recurring severe depression, or a severe and unstable anxiety disorder
You have a personal history of certain neurological conditions, such as epilepsy or another serious neurological disease

If you are a comparison participant or a family member of anyone in the trial:

You have a medical, psychiatric, or physical health condition that would make participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Registry

ClinicalTrials.gov

Start date

30 March 2021

Est. completion

1 March 2036

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Prevalence of synaptic gene deleterious mutations in patients with Autism Spectrum Disorder

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov